Approval · Notice of Compliance 15666 · 2014
CESTEX: Notice of Compliance 15666
Issued June 5, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15666
- Date
- June 5, 2014
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number (din) holder
- Therapeutic class
- Antihelmintic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CESTEX | 01913034 | Marketed |
Medicinal ingredients
- EPSIPRANTEL 12.5 MG per TAB